{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:52:18Z","timestamp":1791100338213,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12032-014-0924-5","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T15:47:56Z","timestamp":1395330476000},"source":"Crossref","is-referenced-by-count":43,"title":["STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma"],"prefix":"10.1007","volume":"31","author":[{"given":"Guo-Shi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Long","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"issue":"2","key":"924_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"924_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07357907.2013.861474","volume":"32","author":"LJ Yang","year":"2014","unstructured":"Yang LJ, Zhou CF, Lin ZX. Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review. Cancer Invest. 2014;32(2):31\u20136.","journal-title":"Cancer Invest"},{"issue":"10","key":"924_CR3","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/stem.185","volume":"27","author":"MM Sherry","year":"2009","unstructured":"Sherry MM, Reeves A, Wu JK, Cochran BH. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells. 2009;27(10):2383\u201392.","journal-title":"Stem Cells"},{"issue":"21","key":"924_CR4","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"19","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000;19(21):2548\u201356.","journal-title":"Oncogene"},{"issue":"9","key":"924_CR5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"924_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-94-007-4719-7_10","volume":"986","author":"K Swiatek-Machado","year":"2013","unstructured":"Swiatek-Machado K, Kaminska B. STAT signaling in glioma cells. Adv Exp Med Biol. 2013;986:189\u2013208.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"924_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1541-7786.MCR-07-2180","volume":"6","author":"EC Brantley","year":"2008","unstructured":"Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res. 2008;6(5):675\u201384.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"924_CR8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.jnen.0000248549.14962.b2","volume":"65","author":"M Mizoguchi","year":"2006","unstructured":"Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol. 2006;65(12):1181\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"924_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2011.12.010","volume":"22","author":"G Kohanbash","year":"2012","unstructured":"Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol. 2012;22(1):70\u20135.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"924_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","volume":"30","author":"H Kiu","year":"2012","unstructured":"Kiu H, Nicholson SE. Biology and significance of the JAK\/STAT signalling pathways. Growth Factors. 2012;30(2):88\u2013106.","journal-title":"Growth Factors"},{"issue":"3","key":"924_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-010-0273-y","volume":"101","author":"C Senft","year":"2011","unstructured":"Senft C, Priester M, Polacin M, Schroder K, Seifert V, Kogel D, et al. Inhibition of the JAK-2\/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol. 2011;101(3):393\u2013403.","journal-title":"J Neurooncol"},{"issue":"39","key":"924_CR12","doi-asserted-by":"crossref","first-page":"32394","DOI":"10.1074\/jbc.M112.393900","volume":"287","author":"Y Ou","year":"2012","unstructured":"Ou Y, Ma L, Dong L, Ma L, Zhao Z, Ma L, et al. Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-gamma and STAT3 protein signaling pathways. J Biol Chem. 2012;287(39):32394\u2013405.","journal-title":"J Biol Chem"},{"issue":"1","key":"924_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 2007;7(1):41\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"924_CR14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1227\/NEU.0b013e3181f1c0cd","volume":"67","author":"SH Kang","year":"2010","unstructured":"Kang SH, Yu MO, Park KJ, Chi SG, Park DH, Chung YG. Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma. Neurosurgery. 2010;67(5):1386\u201395 discussion 95.","journal-title":"Neurosurgery."},{"issue":"3","key":"924_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cyto.2011.05.012","volume":"55","author":"C Piperi","year":"2011","unstructured":"Piperi C, Samaras V, Levidou G, Kavantzas N, Boviatsis E, Petraki K, et al. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry. Cytokine. 2011;55(3):387\u201395.","journal-title":"Cytokine"},{"issue":"3","key":"924_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-010-0195-8","volume":"100","author":"P Birner","year":"2010","unstructured":"Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M. STAT3 tyrosine phosphorylation influences survival in glioblastoma. J Neurooncol. 2010;100(3):339\u201343.","journal-title":"J Neurooncol"},{"issue":"5","key":"924_CR17","first-page":"1173","volume":"26","author":"Y Wang","year":"2011","unstructured":"Wang Y, Chen L, Bao Z, Li S, You G, Yan W, et al. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep. 2011;26(5):1173\u201380.","journal-title":"Oncol Rep"},{"issue":"24","key":"924_CR18","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1158\/1078-0432.CCR-08-1329","volume":"14","author":"M Abou-Ghazal","year":"2008","unstructured":"Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, et al. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008;14(24):8228\u201335.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"924_CR19","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963\u201372.","journal-title":"J Clin Oncol"},{"issue":"4","key":"924_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ejca.2008.11.027","volume":"45","author":"A Dasgupta","year":"2009","unstructured":"Dasgupta A, Raychaudhuri B, Haqqi T, Prayson R, Van Meir EG, Vogelbaum M, et al. Stat3 activation is required for the growth of U87 cell-derived tumours in mice. Eur J Cancer. 2009;45(4):677\u201384.","journal-title":"Eur J Cancer"},{"issue":"7","key":"924_CR21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/neuonc\/not025","volume":"15","author":"M Priester","year":"2013","unstructured":"Priester M, Copanaki E, Vafaizadeh V, Hensel S, Bernreuther C, Glatzel M, et al. STAT3 silencing inhibits glioma single cell infiltration and tumor growth. Neuro Oncol. 2013;15(7):840\u201352.","journal-title":"Neuro Oncol."},{"issue":"1","key":"924_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1593\/neo.91196","volume":"12","author":"L Lin","year":"2010","unstructured":"Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, et al. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Neoplasia. 2010;12(1):39\u201350.","journal-title":"Neoplasia."},{"issue":"2","key":"924_CR23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.20871","volume":"115","author":"S Loeffler","year":"2005","unstructured":"Loeffler S, Fayard B, Weis J, Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer. 2005;115(2):202\u201313.","journal-title":"Int J Cancer"},{"issue":"7120","key":"924_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"5","key":"924_CR25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3171\/2013.7.JNS122417","volume":"119","author":"K Tamura","year":"2013","unstructured":"Tamura K, Aoyagi M, Ando N, Ogishima T, Wakimoto H, Yamamoto M, et al. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J Neurosurg. 2013;119(5):1145\u201355.","journal-title":"J Neurosurg"},{"issue":"15","key":"924_CR26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2174\/0929867311320150004","volume":"20","author":"X Zhang","year":"2013","unstructured":"Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD, Hu SJ. Targeting role of glioma stem cells for glioblastoma multiforme. Curr Med Chem. 2013;20(15):1974\u201384.","journal-title":"Curr Med Chem"},{"issue":"7412","key":"924_CR27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522\u20136.","journal-title":"Nature"},{"issue":"5","key":"924_CR28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/156652409788488739","volume":"9","author":"N Iglesia de la","year":"2009","unstructured":"de la Iglesia N, Puram SV, Bonni A. STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med. 2009;9(5):580\u201390.","journal-title":"Curr Mol Med"},{"issue":"2","key":"924_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.20101","volume":"28","author":"Z Chen","year":"2008","unstructured":"Chen Z, Han ZC. STAT3: a critical transcription activator in angiogenesis. Med Res Rev. 2008;28(2):185\u2013200.","journal-title":"Med Res Rev"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0924-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0924-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0924-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:31:50Z","timestamp":1559442710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0924-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0924-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]},"article-number":"924"}}